Genenta Science (NASDAQ:GNTA) Trading 1.3% Higher - Here's What Happened

Genenta Science S.p.A. (NASDAQ:GNTA - Get Free Report) traded up 1.3% during trading on Monday . The stock traded as high as $4.09 and last traded at $3.88. 7,344 shares traded hands during trading, a decline of 31% from the average session volume of 10,682 shares. The stock had previously closed at $3.83.

Genenta Science Stock Performance

The business has a fifty day moving average of $4.46 and a two-hundred day moving average of $4.59.

Hedge Funds Weigh In On Genenta Science

An institutional investor recently bought a new position in Genenta Science stock. Allianz SE acquired a new stake in Genenta Science S.p.A. (NASDAQ:GNTA - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 103,250 shares of the company's stock, valued at approximately $444,000. Allianz SE owned approximately 0.56% of Genenta Science at the end of the most recent reporting period. Institutional investors and hedge funds own 15.13% of the company's stock.

About Genenta Science

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.